None

FDA approves Perrigo's ANDA for clobetasol propionate shampoo

Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for clobetasol propionate shampoo, 0.05%, the ge...

Perrigo Receives FDA Approval And Commences Launch Of Clobetasol Propionate Shampoo, 0.05%

ALLEGAN, Mich., Aug. 9, 2012 /- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug app...

Perrigo introduces generic Olux-E Foam, 0.05%

Perrigo Company today announced that it has launched clobetasol emulsion propionate foam, 0.05%, the generic equivalent of Olux -E Foam, 0.05%.

Perrigo Commences Launch Of Clobetasol Emulsion Propionate Foam, 0.05%

ALLEGAN, Mich., Feb. 1, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has launched clobetasol emulsion propionate foam, 0.05%, the generic equivalent  of O...

Perrigo Announces Settlement of Clobetasol Propionate E-Foam 0.05% Patent Litigation

ALLEGAN, Mich., June 11, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has agreed to settle its Hatch-Waxman litigation relating to Clobetasol propionate emuls...

Hi-Tech Pharmacal to buy Cormax treatment

Hi-Tech Pharmacal (NASDAQ:HITK) inked a deal with Watson Laboratories on Monday to buy exclusive rights to Cormax, a topical solution to treat scalp conditions.Cormax, a branded version of clobetasol...

PhotoMedex’s XTRAC Laser for Treating Psoriasis Featured in Two Dermatology Medical Journals

PhotoMedex, Inc. (NASDAQ:PHMD) (TASE:PHMD) announces that the Company’s XTRAC® excimer laser was favorably featured in articles that appeared in two dermatology medical trade j...

Hi-Tech Pharmacal Acquires Rights to the Cormax® Brand for its ECR Pharmaceuticals Subsidiary

Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) announced today the signing of a definitive agreement under which Hi-Tech acquired exclusive rights to the Cormax® brand from Watson Lab...

Microparticulate Based Topical Delivery System of Clobetasol Propionate.

Psoriasis is a chronic, autoimmune skin disease affecting approximately 2% of the world's population. Clobetasol propionate which is a superpotent topical corticosteroid is widely used for topical tre...

Review: Limited evidence suggests that clobetasol or mometasone is effective in genital lichen sclerosus.

A Multi-center, Open-label Study to Evaluate the Safety and Efficacy of a Sequential Treatment Regimen of Clobetasol Propionate 0.05% Spray Followed by Calcitriol 3 mg/g Ointment in the Management of Plaque Psoriasis.

Iatrogenic Cushing's syndrome and topical steroid therapy: case series and review of the literature.

Abstract Topical corticosteroids are considered first-line therapy in patients with cronic inflammatory oral mucosal diseases, among them clobetasol propionate is one of the most widely used in oral m...

Treatment of Moderate-to-Severe Psoriasis With Alefacept for Up to One Year: A Case Series.

Background: Alefacept has an established efficacy and safety profile for 12 weeks of treatment of severe chronic plaque type psoriasis. The effectiveness and safety of longer-term continuous use is no...